Brixton Biosciences
About:
Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.
Website: https://www.brixtonbio.com/=
Top Investors: National Institutes of Health, SV Health Investors, Schooner Capital, Sparta Group, Excelestar Ventures
Description:
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for pain treatment. Backed by deep research, the company addresses crucial unmet needs in pain management, which has historically been dominated by systemic medicine. Brixton Biosciences' innovative therapeutics, such as its novel Neural Ice™, provide pain relief in a single, safe, and easy drug-free injectable that is a non-addictive, locally targeted, and comparatively long-lasting solution.
$35M
Cambridge, Massachusetts, United States
2018-01-01
info(AT)brixtonbio.com
Lilit Garibyan, R. Rox Anderson, Sameer Sabir
1-10
2024-10-25
Private
© 2025 bioDAO.ai